Neuralstem Announces Publication of NSI-189 Preclinical Data in Journal of Cellular Physiology

GERMANTOWN, Md., Feb. 28 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, announced the recent publication of preclinical data on NSI-189 in Journal of Cellular Physiology.  The study demonstrated that NSI-189 improved behavioral function recovery and enhanced hippocampal synaptic [...]